GENEVA, Feb. 22 -- ARROMAX PHARMATECH CO., LTD. (4th Floor, Building 6, Zone C, Dongfang Industrial Park, SIPSuzhou, Jiangsu 215000), 安润医药科技(苏州)有限公司 (中国江苏省苏州市工业园区东坊产业园C区6号楼4层) filed a patent application (PCT/CN2025/103835) for "PHARMACEUTICALLY ACCEPTABLE SALT OF TYROSINE KINASE INHIBITOR, CRYSTAL, PREPARATION METHOD, AND USE" on Jun 26, 2025. With publication no. WO/2026/036924, the details related to the patent application was published on Feb 19, 2026.
Notably, the patent application was submitte...